Continuity of routine immunization programs in Canada during the COVID-19 pandemic

  1. Hannah Sell
  2. Ali Assi
  3. S. Michelle Driedger
  4. Ève Dubé
  5. Arnaud Gagneur
  6. Samantha B. Meyer
  7. Joan Robinson
  8. Manish Sadarangani
  9. Matthew Tunis
  10. Shannon E. MacDonald

Reviewed by

Read the full article

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.vaccine.2021.08.044
  2. ScreenIT

    SciScore for 10.1101/2021.03.22.21254121: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: Interested individuals were emailed an information sheet and consent form.
    IRB: Ethical approval for this study was obtained from the Health Research Ethics Board at the University of Alberta.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Descriptive analysis of response counts was performed using Microsoft Excel.
    Microsoft Excel
    suggested: (Microsoft Excel, RRID:SCR_016137)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Strengths and Limitations: A strength of this study was the variety of perspectives that were obtained on routine immunization programs during the COVID-19 pandemic from most P/Ts. As well, the use of key informant interviews rather than survey methods allowed us to gather in-depth perspectives on routine immunization programs in each P/T. However, as only a few select individuals were interviewed from each P/T, the perspectives gathered are not representative of entire P/Ts. Furthermore, there may be variation in individual perspectives across a single P/T, although the perspectives shared were very consistent within a given P/T. At the time the interviews were conducted, most P/Ts did not have up-to-date information on routine immunization coverage rates during the pandemic. Similarly, given that the COVID-19 pandemic is ongoing and there is a lack of available information on immunization coverage rates, we do not know which P/T strategies were the most effective in ensuring continuity of routine immunization programs. Implications: This study adds to existing literature by identifying and synthesizing pan-national public health approaches to the continuity of routine immunization programs during the pandemic. Results can inform policymakers and program planners and can assist in future development of national guidelines. As well, we anticipate that the information in this study will enable P/Ts to learn from one another by comparing their approach to maintaining routine im...

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2021.03.22.21254121v1 on medRxiv